potent immunosuppressive enzyme, we tested the hypothesis that HO-1 could mediate the immunosuppressive effects of MSCs. We generated adult rat MSCs that inhibited T cell proliferation in vitro. These MSCs expressed both HO-1 and iNOS. In vitro, whereas neither HO-1 nor iNOS inhibition alone could interfere with the immunosuppressive properties of rat MSCs, simultaneous inhibition of both enzymes restored T cell proliferation. In vivo, injection of MSCs significantly delayed heart allograft rejection, and inhibition of either HO-1 or iNOS totally reversed the protective activity of MSCs, inducing rejection. Adult human MSCs also expressed HO-1 and in these cells, HO-1 inhibition was sufficient to completely block their immunosuppressive capacity. In conclusion, we show, for the first time, that HO-1 mediates the immunosuppressive properties of rat and human MSC.
INTRODUCTION
The possibility that mesenchymal stem cells (MSCs) could modulate the immune response in vivo 1 was first suggested by skin graft experiments in non-human primates. Strong nonspecific immunosuppressive properties have been reported in vitro for both humans and rodent MSC 2-4 . Various mechanisms have been proposed to explain such properties, including production of transforming growth factor beta (TGFβ) 5 , hepatocyte growth factor, PGE2 6 , IL-10 5 , and indoleamine 2,3-dioxygenase (IDO) 7, 8 , as well as suppression of antigen presenting cell maturation 9, 10 . A recent study demonstrated that the suppressive activity of murine MSCs is dependent on inducible NO synthase expression
11
. However, the precise mechanism of action of these cells remains poorly understood. It is interesting to note, however, that MSCs are not intrinsically immunoprivileged since allogeneic MSCs can induce a memory T cell response 12 .
Heme oxygenases (HO) are the rate-limiting intracellular enzymes that degrade heme to biliverdin, CO and free divalent iron 13 . The inducible form, HO-1, has been described as an anti-inflammatory 13 and immunosuppressive molecule 14 Furthermore, HO-1 can mediate the effect of molecules such as IL-10 and NO 15 .We thus hypothesized that HO-1 could contribute to the immunosuppressive properties of adult rat and human mesenchymal stem cells.
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STUDY DESIGN
This study was approved by the Institutional Review Board of Nantes University.
MSC culture
Adult rat MSCs were obtained from LEW.1A and LEW.1W (complete MHC I and II mismatch) bone marrow cells collected by flushing femurs and tibias with alpha MEM medium supplemented with 20% fetal calf serum, penicillin and streptomycin. Adult rat MSCs were regularly split using trypsin and used before passage 4. Culture of human MSCs was performed in the same conditions from bone marrow aspirates from healthy volunteer donors who had provided informed consent. Adherent cells displayed a morphology and phenotype typical of MSCs, as shown by the expression of CD90, CD73, CD105 and the virtual absence of CD45-positive cells (Table S1 ). Their identification as MSCs was further confirmed by their ability to differentiate into adipocytes and osteoblasts under appropriate culture conditions (data not shown).
Immunocytology and western blot
The anti-rat and anti-human HO-1 polyclonal antisera were from Stressgen (San Diego, CA).
The rabbit anti-iNOS polyclonal antibody was from Sigma (St. Louis, MO). Primary antibody binding was determined using FITC-conjugated goat anti-rabbit IgG (Pierce, Rockford, USA).
Anti-CD45 staining was performed using the OX1 + OX30 clones.
Western blot analyses were performed as previously described 14 .
Allogeneic stimulation
In rat experiments, T cells (95-98 % pure) from LEW 1A lymph nodes were stimulated by allogeneic LEW.1W antigen presenting cells (APCs, Nycodenz low density fraction from the spleen) in the absence or presence of LEW.1A MSCs. Proliferation was measured by assessment of thymidine uptake. In human MLRs, irradiated allogeneic PBMC were used as stimulators of non irradiated PBMC.
Transplantations
Heterotopic cardiac allografts were performed as previously described 16 .
RESULTS AND DISCUSSION
Adult rat MSCs were able to suppress T cell proliferation by 75-90 % in response to allogeneic stimulation at a MSC / T cell ratio of 1:1 (Fig 1A) or in response to ConA activation ( Figure S1 ). This suppressive activity was dose-dependent ( Fig 1A) and MHC independent since adult rat LEW.1A MSCs significantly inhibited LEW.1A and 1W T lymphocyte proliferation ( Figure S1 ).
The main objective of the present work was to determine whether HO-1 is involved in the immunosuppressive effect of MSCs. We thus analyzed HO-1 protein in adult rat MSCs and found that the large majority did express HO-1 (Fig 1B) . HO-1 protein levels were not modified by IFN-γ treatment or during MLR (Fig 1B) . Fig 1B) . The same results were observed using western blots in the same conditions ( Fig   1B) . In contrast, IDO protein was undetectable, even after IFN-γ treatment and MLR coculture (not shown).
To further determine a functional immunosuppressive role for HO-1 expressed by MSCs, we next co-cultured LEW 1A MSCs with LEW 1A T cells and LEW 1W APC in the presence of the HO-1-specific inhibitor SnPP (Fig 1C) . In the absence of any treatment, MSCs inhibited T cell proliferation by 90 % at a 1:1 ratio (Fig 1C) . This T cell suppression was not affected by HO-1 inhibition. The same results were observed upon inhibition of iNOS by L-NMMA treatment (Fig 1C) . In clear contrast, however, simultaneous inhibition of both enzymes (SnPP/L-NMMA co-treatment) significantly, albeit partially, restored T cell proliferation.
We next analyzed the immunosuppressive capacity of MSCs in vivo in a rat model of cardiac allotransplantation. Administration of donor MSCs seven and one day before heart transplantation significantly prolonged allograft survival, with a mean graft survival of 23 +/-13 days (6, 7, 7, 28, 29, 29, 32 36, 36 (n = 9)) compared to 6 days in untreated controls ( Fig   1D) . These data show that donor rat MSCs also display suppressive activity in vivo. In order to assess the role of HO-1 and iNOS in the suppressive activity of rat MSCs in vivo, adult rat MSC-treated heart allograft recipients were additionally co-treated with inhibitors of HO-1 and iNOS (SnPP and aminoguanidine, respectively) from the day of MSC administration until rejection. As shown in Fig 1D , such treatment totally reversed the protective effect of adult
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These results show that HO-1 and iNOS are implicated in the suppressive activity of adult rat MSCs both in vitro and in vivo. Our data are in contradiction with a recent study where adult rat MSCs were unable to prolong heart allograft survival in a Lewis to ACI combination 19 .
Nevertheless, it is worth noting that, in contrast to the latter study, here we only used cells that had undergone less than 4 passages, since we found HO-1 expression as well as immunosuppressive function to be very rapidly down regulated over time in culture ( Figure   S2 ).
Our results led us to analyze HO-1 expression in human MSCs. Virtually all human MSCs expressed HO-1 (Fig 2A) . ) seven days before (black circle, n = 5), at the time of Lewis 1W heat transplantation (black triangle, n = 5) or at both times (5.10 6 and 7.10 6 Lewis 1W MSC respectively) (white triangle, n = 5). Rats receiving two donor MSC injections were treated from the day of MSC administration by intraperitoneal injections of SnPP (15 µg/rat) once every four days and aminoguanidine (Sigma-Aldrich, Saint Quentin Fallavier, France) (0.1 g/rat) twice a day until rejection (white diamond, n = 9), or with SnPP (15 µg/rat) alone (white square, n = 5) or aminoguanidine (0.1 g/rat) alone (white circle). Graft survival was monitored daily by abdominal palpation. 
Figure 2
